Literature DB >> 6885886

Avascular necrosis of the hip in the sickle cell hemoglobinopathies.

J I Sebes, A P Kraus.   

Abstract

Two hundred and eighty-one patients with sickle cell disease were studied clinically and radiographically with emphasis on diagnosis of epiphyseal abnormalities and potential complications of hip replacement. Nineteen percent of patients with hemoglobin SS disease had avascular necrosis of the femoral head (ANF) while a 9% incidence was found in hemoglobin SC disease. Twenty of 47 patients with ANF had no hip pain. The degree of anemia did not correlate well with symptoms. Thirteen patients with avascular necrosis of the hip underwent hip replacement and four developed prosthesis-related complications.

Entities:  

Mesh:

Year:  1983        PMID: 6885886

Source DB:  PubMed          Journal:  J Can Assoc Radiol        ISSN: 0008-2902


  5 in total

Review 1.  [Aseptic necrosis of the femoral head in young adults].

Authors:  H M Vasey
Journal:  Int Orthop       Date:  1984       Impact factor: 3.075

Review 2.  Beyond the definitions of the phenotypic complications of sickle cell disease: an update on management.

Authors:  Samir K Ballas; Muge R Kesen; Morton F Goldberg; Gerard A Lutty; Carlton Dampier; Ifeyinwa Osunkwo; Winfred C Wang; Carolyn Hoppe; Ward Hagar; Deepika S Darbari; Punam Malik
Journal:  ScientificWorldJournal       Date:  2012-08-01

3.  The choice of arthroplasty for secondary osteoarthritis of the hip joint following avascular necrosis of the femoral head in sicklers.

Authors:  Temitope O Alonge; Wuraola A Shokunbi
Journal:  J Natl Med Assoc       Date:  2004-05       Impact factor: 1.798

Review 4.  Orthopaedic manifestations of sickle-cell disease.

Authors:  M H Huo; G E Friedlaender; J S Marsh
Journal:  Yale J Biol Med       Date:  1990 May-Jun

5.  Revision hip arthroplasty in sickle cell disease.

Authors:  Aydýner Kalacý; Cenk Ozkan; Emre Toğrul
Journal:  Ann Saudi Med       Date:  2007 Mar-Apr       Impact factor: 1.526

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.